The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
People said the same about crcl when new chairman arrived with a fresh plan last spring at 4m market cap, it’s now 14m and made an oil discovery. Sometimes don’t kick things down until you’ve given them a chance eh
Can’t be far away now guys. Hopefully this is what we endured the pain of waiting for two spuds for! Everything in the last RNS on the drill sounds very positive. Let’s see what Tobias is about!!
Funded to 2026 and won’t be last of the commercial deals. If Thermo Fisher was a taster then things look good. I’ve applied for a few more with the retail offer. Hopefully I get them all, looks like the main placing went fast!
Lol. Its going above 3 quid mate close your short .. aim 100 and mid caps look strong now
Can you imagine the scramble to get in when the Thermo Fisher payment arrives? These last raised cash at 35p and that was before they signed commercial deals. There will be plenty support for this in size and not at these depressed prices
Looks like a bottom has been found
Document filed. Terms still in it.. as per October 22. I’d expect a date for Tete voting it in soon maybe. A cracking deal for MBO
https://www.sec.gov/Archives/edgar/data/1986694/000149315224002939/formf-4a.htm
(7)
Assumes 400,000 Contingent Shares to MobilityOne. Following the consummation of the share sale pursuant to the SSA, MobilityOne will receive cash payments of $8.8 million and $4.4 million from Super Apps within 14 days and 180 days, respectively, of completion of the Business Combination. As further consideration of MobilityOne’s undertakings and guarantee of achieving the Revenue Target, Super Apps shall cause TETE to issue part of the Contingent Shares to MobilityOne Limited (which is the parent of MobilityOne) with aggregate value of $4.4 million upon OneShop Retail achieving the Revenue Target. The Contingent Shares will be issued at a price of $10.00 per share. In the event that the Business Combination is consummated, but the Revenue Target is not achieved, the Share Sale will continue, but MobilityOne will not be entitled to the Contingent Shares.
If anything it shakes LB up and gets them to act, knowing there’s other interested enquiries, the exclusive bubble they were living in has now burst. It creates urgency and a stronger negotiating position for CMET.
Discount to major recent funding, Fill your boots.